Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company. The company has entered into several co-discovery agreements to expand its portfolio and has also signed license agreements for its transgenic mouse platforms with select partners to further Next-Gen drug invention.